Patents by Inventor Yaodong Wu

Yaodong Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10821104
    Abstract: A five-membered heterocyclic amide WNT pathway inhibitor having the following general structural formula: The five-membered heterocyclic amide WNT pathway inhibitor has a remarkable anti-tumor activity based on a target-based rational drug design, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: November 3, 2020
    Assignee: Suzhou Sinovent Pharmaceuticals Co., Ltd.
    Inventors: Yonghui Wang, Yan Zhu, Juan Zhou, Yujun Gao, Shiqun Wang, Dong Wang, Wandeng Liu, Ximing Shen, Binbin Hong, Tao Liu, Yaodong Wu, Chunqi Li
  • Patent number: 10710993
    Abstract: The present invention discloses a compound for regulating protein kinase activity and used for treating or preventing diseases associated with protein kinases. Specifically, the present invention relates to a benzofuran pyrazole amine protein kinase inhibitor which belongs to compounds that regulate anaplastic lymphoma kinase (ALK), and provides a method of preparing such a compound and a pharmaceutical use of such a compound in the treatment or prevention of diseases associated with ALK. The inhibitor can solve the problem of the drug resistance of the first generation and the second generation of ALK inhibitors.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: July 14, 2020
    Assignee: HANGZHOU REX PHARMACEUTICAL CO., LTD.
    Inventors: Yonghui Wang, Juan Zhou, Yujun Gao, Dong Wang, Binbin Hong, Ximing Shen, Yaodong Wu, Chunqi Li
  • Publication number: 20190225600
    Abstract: The present invention discloses a compound for regulating protein kinase activity and used for treating or preventing diseases associated with protein kinases. Specifically, the present invention relates to a benzofuran pyrazole amine protein kinase inhibitor which belongs to compounds that regulate anaplastic lymphoma kinase (ALK), and provides a method of preparing such a compound and a pharmaceutical use of such a compound in the treatment or prevention of diseases associated with ALK. The inhibitor can solve the problem of the drug resistance of the first generation and the second generation of ALK inhibitors.
    Type: Application
    Filed: June 27, 2017
    Publication date: July 25, 2019
    Inventors: Yonghui WANG, Juan ZHOU, Yujun GAO, Dong WANG, Binbin HONG, Ximing SHEN, Yaodong WU, Chunqi LI
  • Patent number: 10265821
    Abstract: An automatic component loading system is disclosed. The automatic component loading system has a loading device, a conveying device having a plurality of first pin receiving slots and a plurality of first component receiving trays positioned around a circumference of the conveying device, and a position correcting device having at least one pin that corresponds with the plurality of first pin receiving slots.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: April 23, 2019
    Assignees: Tyco Electronics (Shanghai) Co. Ltd., Tyco Electronics (Shenzhen) Co. Ltd., Shenzhen AMI Technology Co., Ltd
    Inventors: Yingcong Deng, Dandan Zhang, Roberto Francisco-Yi Lu, Yaodong Wu, Zhenliang Chen, Zhao Li, Jin Su, Zhi Li, Qinglong Zeng
  • Publication number: 20180271846
    Abstract: The present invention discloses a five-membered heterocyclic amide WNT pathway inhibitor, which belongs to a compound that regulates the activity of a Wnt signaling pathway, and provides a method for preparing such a compound, and the use of such a compound in preparing a medicament that antagonizes the Wnt signaling pathway. The five-membered heterocyclic amide WNT pathway inhibitor provided by the invention has a remarkable anti-tumor activity based on a target-based rational drug design of, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.
    Type: Application
    Filed: December 7, 2016
    Publication date: September 27, 2018
    Inventors: Yonghui WANG, Yan ZHU, Juan ZHOU, Yujun GAO, Shiqun WANG, Dong WANG, Wandeng LIU, Ximing SHEN, Binbin HONG, Tao LIU, Yaodong WU, Chunqi LI
  • Patent number: 9944670
    Abstract: The invention provides gemcitabine derivatives shown in the following formula (I) and preparation methods thereof. The invention further relates to a pharmaceutical composition which comprising the said gemcitabine derivatives in an effective amount and a pharmaceutically acceptable excipient or additive. The invention further provides use of the said derivatives for preparing anti-tumor drugs. The compound designed by the invention is novel in structure and has a remarkable anti-tumor activity. According to the compound designed by the invention, the preparation starting materials have extensive sources and are easily obtained, the preparation method is simple and easy to operate, and the yield of the product is high, so that industrial production on a large scale is facilitated.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: April 17, 2018
    Assignees: HANGZHOU YUANCHANG MEDICAL SCI-TECH CO., LTD, HANGZHOU MINSHENG INSTITUTES FOR PHARMA RESEARCH CO., LTD
    Inventors: Yaodong Wu, Jiaqi Shan, Ximing Shen, Chunxia Wu, Binnan Huang
  • Publication number: 20160304550
    Abstract: The invention provides gemcitabine derivatives shown in the following formula (I) and preparation methods thereof. The invention further relates to a pharmaceutical composition which comprising the said gemcitabine derivatives in an effective amount and a pharmaceutically acceptable excipient or additive. The invention further provides use of the said derivatives for preparing anti-tumor drugs. The compound designed by the invention is novel in structure and has a remarkable anti-tumor activity. According to the compound designed by the invention, the preparation starting materials have extensive sources and are easily obtained, the preparation method is simple and easy to operate, and the yield of the product is high, so that industrial production on a large scale is facilitated.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 20, 2016
    Inventors: Yaodong Wu, Jiaqi Shan, Ximing Shen, Chunxia Wu, Binnan Huang
  • Publication number: 20160128243
    Abstract: An automatic component loading system is disclosed. The automatic component loading system has a loading device, a conveying device having a plurality of first pin receiving slots and a plurality of first component receiving trays positioned around a circumference of the conveying device, and a position correcting device having at least one pin that corresponds with the plurality of first pin receiving slots.
    Type: Application
    Filed: October 30, 2015
    Publication date: May 5, 2016
    Applicants: Tyco Electronics (Shanghai) Co. Ltd., Tyco Electronics (Shenzhen) Co. Ltd, Shenzhen AMI Technology Co., Ltd
    Inventors: Yingcong Deng, Dandan Zhang, Roberto Francisco-Yi Lu, Yaodong Wu, Zhenliang Chen, Zhao Li, Jin Su, Zhi Li, Qinglong Zeng